{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:16:22Z","timestamp":1792512982843,"version":"4.5.0"},"reference-count":165,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiovascular diseases (CVDs), characterized by a high incidence rate and high mortality, have become the leading cause of death globally. CVDs include coronary heart disease, stroke, hypertension, and peripheral vascular diseases. In China, the death rate of CVDs ranks the first in all major diseases. At present, the main methods to treat ischemic heart disease are drug therapy, intervention and operation. These methods only alleviate symptoms of heart failure and myocardial ischemia and improve patients' quality of life by partially restoring myocardial reperfusion. Due to the extensive irreversible necrosis of myocardial cells caused by ischemia and hypoxia, these methods cannot reverse the damage, resulting in suboptimal long-term outcomes. Although mature cardiomyocytes have been proved not to be terminally differentiated cells, they have very limited ability of regeneration and proliferation, so they can not completely replace the damaged myocardium and restore the contractile function. Although heart transplantation can replace the damaged heart, its clinical application and promotion are limited by the source of donor, expensive cost, immune rejection, and ethical problems. It has become an urgent task for clinical medicine to seek new and better treatment. The main content of this paper is to explore the application of stem cells and gene technology in the treatment of myocardial infarction (MI).<\/jats:p>","DOI":"10.3389\/fcvm.2025.1540066","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:52:38Z","timestamp":1739947958000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Two promising approaches in the treatment of myocardial infarction: stem cells and gene therapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Shan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingkai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12872-023-03231-w","article-title":"The global prevalence of myocardial infarction: a systematic review and meta-analysis","volume":"23","author":"Salari","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2023.12.009","article-title":"Stem cell-based therapy in cardiac repair after myocardial infarction: promise, challenges, and future directions","volume":"188","author":"Yan","year":"2024","journal-title":"J Mol Cell Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1152\/physrev.00009.2023","article-title":"Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing","volume":"104","author":"Barr\u00e8re-Lemaire","year":"2024","journal-title":"Physiol Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/biomedicines9121836","article-title":"iPSC therapy for myocardial infarction in large animal models: land of hope and dreams","volume":"9","author":"Mart\u00ednez-Falguera","year":"2021","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"101980","DOI":"10.1016\/j.arr.2023.101980","article-title":"The beneficial effects of mesenchymal stem cells and their exosomes on myocardial infarction and critical considerations for enhancing their efficacy","volume":"89","author":"Ala","year":"2023","journal-title":"Ageing Res Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41536-025-00394-2","article-title":"Revitalizing the heart: strategies and tools for cardiomyocyte regeneration post-myocardial infarction","volume":"10","author":"Bois","year":"2025","journal-title":"NPJ Regen Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11886-024-02189-1","article-title":"Molecular regulation of cardiomyocyte maturation","volume":"27","author":"Shewale","year":"2025","journal-title":"Curr Cardiol Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1016\/j.ymthe.2024.07.018","article-title":"CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia\/reperfusion injury in mice","volume":"32","author":"Lerchenm\u00fcller","year":"2024","journal-title":"Mol Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.3390\/ijms25116262","article-title":"Modified mRNA-mediated CCN5 gene transfer ameliorates cardiac dysfunction and fibrosis without adverse structural remodeling","volume":"25","author":"Song","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ahj.2019.06.009","article-title":"Long-term follow-up and safety assessment of angiogenic gene therapy trial VIF-CAD: transcatheter intramyocardial administration of a bicistronic plasmid expressing VEGF-A165\/bFGF cDNA for the treatment of refractory coronary artery disease","volume":"215","author":"Kuku\u0142a","year":"2019","journal-title":"Am Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCRESAHA.118.312823","article-title":"Safety and efficacy of intracoronary infusion of allogeneic human cardiac stem cells in patients with ST-segment elevation myocardial infarction and left ventricular dysfunction","volume":"123","author":"Fern\u00e1ndez-Avil\u00e9s","year":"2018","journal-title":"Circ Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCRESAHA.117.311466","article-title":"TIME trial: effect of timing of stem cell delivery following ST-elevation myocardial infarction on the recovery of global and regional left ventricular function: final 2-year analysis","volume":"122","author":"Traverse","year":"2018","journal-title":"Circ Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jcyt.2023.01.013","article-title":"Cardiac cell therapies for the treatment of acute myocardial infarction in mice: systematic review and meta-analysis","volume":"25","author":"Lang","year":"2023","journal-title":"Cytotherapy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"ii7","DOI":"10.1136\/hrt.2005.062026","article-title":"Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction","volume":"91","author":"Cleland","year":"2005","journal-title":"Heart"},{"key":"B17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12265-020-10067-8","article-title":"Adult cardiomyocyte proliferation: a new insight for myocardial infarction therapy","volume":"14","author":"Zhu","year":"2020","journal-title":"J Cardiovasc Transl Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ahj.2011.07.020","article-title":"A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction","volume":"162","author":"Povsic","year":"2011","journal-title":"Am Heart J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/CIRCRESAHA.119.315216","article-title":"Transplantation of human umbilical cord blood-derived cellular fraction improves left ventricular function and remodeling after myocardial ischemia\/reperfusion","volume":"125","author":"Zhao","year":"2019","journal-title":"Circ Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8340257","DOI":"10.1155\/2016\/8340257","article-title":"Pivotal cytoprotective mediators and promising therapeutic strategies for endothelial progenitor cell-based cardiovascular regeneration","volume":"2016","author":"Kim","year":"2016","journal-title":"Stem Cells Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41419-020-2508-y","article-title":"Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis","volume":"11","author":"Wu","year":"2020","journal-title":"Cell Death Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/biomedicines8060157","article-title":"Dose-independent therapeutic benefit of bone marrow stem cell transplantation after MI in mice","volume":"8","author":"Zarniko","year":"2020","journal-title":"Biomedicines"},{"key":"B23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12967-020-02504-8","article-title":"Mesenchymal stem cell mediates cardiac repair through autocrine, paracrine and endocrine axes","volume":"18","author":"Sid-Otmane","year":"2020","journal-title":"J Transl Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/CIRCRESAHA.117.308428","article-title":"Multimodal regulation of cardiac myocyte proliferation","volume":"121","author":"Yuan","year":"2017","journal-title":"Circ Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/CIRCRESAHA.118.313971","article-title":"Distinguishing cardiomyocyte division from binucleation","volume":"123","author":"Kadow","year":"2018","journal-title":"Circ Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.RES.83.1.1","article-title":"Ventricular myocytes are not terminally differentiated in the adult mammalian heart","volume":"83","author":"Piero","year":"1998","journal-title":"Circ Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/CIRCRESAHA.115.307017","article-title":"Functional recovery of a human neonatal heart after severe myocardial infarction","volume":"118","author":"Haubner","year":"2016","journal-title":"Circ Res"},{"key":"B29","first-page":"37","article-title":"Can grafted cardiomyocytes colonize peri-infarct myocardial areas?","volume":"94","author":"Scorsin","year":"1996","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nature06800","article-title":"Stem-cell therapy for cardiac disease","volume":"451","author":"Segers","year":"2008","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1016\/j.athoracsur.2019.03.028","article-title":"Long-term outcome of ischemic cardiomyopathy after autologous myoblast cell-sheet implantation","volume":"108","author":"Yamamoto","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e003918","DOI":"10.1161\/JAHA.116.003918","article-title":"Phase I clinical trial of autologous stem cell-sheet transplantation therapy for treating cardiomyopathy","volume":"6","author":"Miyagawa","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasche","year":"2008","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fcell.2020.00263","article-title":"Down-regulated exosomal MicroRNA-221 - 3p derived from senescent mesenchymal stem cells impairs heart repair","volume":"8","author":"Sun","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.7150\/thno.47893","article-title":"Analysis of mesenchymal stem cell proteomes in situ in the ischemic heart","volume":"10","author":"Han","year":"2020","journal-title":"Theranostics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/ar.a.10106","article-title":"Hematopoietic cells from bone marrow have the potential to differentiate into cardiomyocytes in vitro","volume":"274","author":"Eisenberg","year":"2003","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nature02460","article-title":"Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium","volume":"428","author":"Balsam","year":"2004","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1042\/CS20050087","article-title":"Haematopoietic stem cells and repair of the ischaemic heart","volume":"109","author":"Balsam","year":"2005","journal-title":"Clin Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cardiores.2004.11.009","article-title":"Hematopoietic stem cells do not repair the infarcted mouse heart","volume":"65","author":"Deten","year":"2005","journal-title":"Cardiovasc Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.arcmed.2019.12.014","article-title":"Autologous CXCR4+ hematopoietic stem cells injected into the scar tissue of chronic myocardial infarction patients normalizes tissue contractility and perfusion","volume":"51","author":"Aceves","year":"2020","journal-title":"Arch Med Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00005-016-0394-x","article-title":"Adipose-derived stem cells as a tool in cell-based therapies","volume":"64","author":"Bajek","year":"2016","journal-title":"Arch Immunol Ther Exp"},{"key":"B44","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41374-018-0181-x","article-title":"Preconditioned adipose-derived stem cells ameliorate cardiac fibrosis by regulating macrophage polarization in infarcted rat hearts through the PI3K\/STAT3 pathway","volume":"99","author":"Lee","year":"2019","journal-title":"Lab Invest"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1002\/jcp.26386","article-title":"Stem cells rescue cardiomyopathy induced by P. Gingivalis-LPS via miR-181b","volume":"233","author":"Chen","year":"2018","journal-title":"J Cell Physiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","article-title":"Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells","volume":"109","author":"Rehman","year":"2004","journal-title":"Circulation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1084\/jem.20040440","article-title":"A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential","volume":"200","author":"Kogler","year":"2004","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"I96","DOI":"10.1161\/01.CIRCULATIONAHA.105.524678","article-title":"Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model","volume":"112","author":"Kim","year":"2005","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"5412478","DOI":"10.1155\/2018\/5412478","article-title":"Expanded CD133(+) cells from human umbilical cord blood improved heart function in rats after severe myocardial infarction","volume":"2018","author":"Correa","year":"2018","journal-title":"Stem Cells Int"},{"key":"B50","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.biopha.2018.12.095","article-title":"Effect of intravenous transplantation of hUCB-MSCs on M1\/M2 subtype conversion in monocyte\/macrophages of AMI mice","volume":"111","author":"Peng","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00395-020-0781-7","article-title":"M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment","volume":"115","author":"Liu","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1093\/eurheartj\/ehaa541","article-title":"Intracoronary ALLogeneic heart STem cells to achieve myocardial regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial","volume":"41","author":"Makkar","year":"2020","journal-title":"Eur Heart J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/eurheartj\/ehx454","article-title":"Cardiac and systemic rejuvenation after cardiosphere-derived cell therapy in senescent rats","volume":"38","author":"Grigorian-Shamagian","year":"2017","journal-title":"Eur Heart J"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1161\/CIRCRESAHA.118.313005","article-title":"Lack of cardiac improvement after cardiosphere-derived cell transplantation in aging mouse hearts","volume":"123","author":"Zhao","year":"2018","journal-title":"Circ Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13287-017-0481-x","article-title":"Cardiosphere-derived cells do not improve cardiac function in rats with cardiac failure","volume":"8","author":"Kasai-Brunswick","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"B56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bioactmat.2020.01.003","article-title":"Heart regeneration with human pluripotent stem cells: prospects and challenges","volume":"5","author":"Jiang","year":"2020","journal-title":"Bioactive Materials"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.3390\/cells9102270","article-title":"Cell mechanics in embryoid bodies","volume":"9","author":"Zeevaert","year":"2020","journal-title":"Cells"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3727\/096368911X627561","article-title":"Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction","volume":"21","author":"Glass","year":"2012","journal-title":"Cell Transplant"},{"key":"B59","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3267","article-title":"Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies","volume":"19","author":"Lee","year":"2013","journal-title":"Nat Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1038\/s41467-018-04011-3","article-title":"Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells","volume":"9","year":"2018","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1096\/fj.06-6769com","article-title":"Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response","volume":"21","author":"Nussbaum","year":"2007","journal-title":"FASEB J"},{"key":"B62","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Rep"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e12942","DOI":"10.1111\/cpr.12942","article-title":"Hyaluronate supports hESC-cardiomyocyte cell therapy for cardiac regeneration after acute myocardial infarction","volume":"53","author":"Tan","year":"2020","journal-title":"Cell Prolif"},{"key":"B64","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat Methods"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1021\/mp2001704","article-title":"Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium","volume":"8","author":"Singla","year":"2011","journal-title":"Mol Pharm"},{"key":"B67","doi-asserted-by":"publisher","first-page":"eaay1318","DOI":"10.1126\/scitranslmed.aay1318","article-title":"Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine","volume":"12","author":"Gao","year":"2020","journal-title":"Sci Transl Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13287-020-01811-7","article-title":"Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes","volume":"11","author":"Jiang","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"B69","doi-asserted-by":"publisher","first-page":"eaax2992","DOI":"10.1126\/scitranslmed.aax2992","article-title":"Transplanted microvessels improve pluripotent stem cell-derived cardiomyocyte engraftment and cardiac function after infarction in rats","volume":"12","author":"Sun","year":"2020","journal-title":"Sci Transl Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1101\/gad.1712408","article-title":"Myc\u2019s broad reach","volume":"22","author":"Eilers","year":"2008","journal-title":"Genes Dev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nbt1374","article-title":"Generation of induced pluripotent stem cells without myc from mouse and human fibroblasts","volume":"26","author":"Nakagawa","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"165405","DOI":"10.1016\/j.bbadis.2019.01.031","article-title":"Generation of induced pluripotent stem cells using elastin like polypeptides as a non-viral gene delivery system","volume":"1866","author":"Lee","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2147\/IJN.S73961","article-title":"Reprogramming fibroblasts to pluripotency using arginine-terminated polyamidoamine nanoparticles based non-viral gene delivery system","volume":"9","author":"Zhu","year":"2014","journal-title":"Int J Nanomed"},{"key":"B75","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","article-title":"Generation of induced pluripotent stem cells using recombinant proteins","volume":"4","author":"Zhou","year":"2009","journal-title":"Cell Stem Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.119.042476","article-title":"In vivo AAV-CRISPR\/Cas9-mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia","volume":"141","author":"Zhao","year":"2020","journal-title":"Circulation"},{"key":"B77","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2174\/156652311798192789","article-title":"Development of liposomes and pseudovirions with fusion activity for efficient gene delivery","volume":"11","author":"Kaneda","year":"2011","journal-title":"Curr Gene Ther"},{"key":"B78","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.mvr.2010.03.014","article-title":"Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction","volume":"80","author":"Zhao","year":"2010","journal-title":"Microvasc Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cardiores.2004.12.002","article-title":"The biology of vascular endothelial growth factors","volume":"65","author":"Tammela","year":"2005","journal-title":"Cardiovasc Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/sj.mt.6300175","article-title":"Current status of cardiovascular gene therapy","volume":"15","author":"Rissanen","year":"2007","journal-title":"Mol Ther"},{"key":"B81","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cardiores.2006.10.011","article-title":"Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model","volume":"73","author":"Hao","year":"2007","journal-title":"Cardiovasc Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/gt.2016.35","article-title":"Vascular endothelial growth factor-A gene electrotransfer promotes angiogenesis in a porcine model of cardiac ischemia","volume":"23","author":"Bulysheva","year":"2016","journal-title":"Gene Ther"},{"key":"B83","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1148\/radiol.2451061077","article-title":"Injection of adeno-associated viral vector encoding vascular endothelial growth factor gene in infarcted swine myocardium: mR measurements of left ventricular function and strain","volume":"245","author":"Jacquier","year":"2007","journal-title":"Radiology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/01.RES.0000217342.83731.89","article-title":"Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs","volume":"98","author":"Ferrarini","year":"2006","journal-title":"Circ Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the euroinject one trial","volume":"45","author":"Kastrup","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1093\/eurheartj\/ehx352","article-title":"Adenoviral intramyocardial VEGF-DDeltaNDeltaC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I\/IIa study with 1-year follow-up","volume":"38","author":"Hartikainen","year":"2017","journal-title":"Eur Heart J"},{"key":"B87","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cyto.2016.12.005","article-title":"VEGF gene therapy cooperatively recruits molecules from the immune system and stimulates cell homing and angiogenesis in refractory angina","volume":"91","author":"Eibel","year":"2017","journal-title":"Cytokine"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/aps.2018.14","article-title":"Anti-inflammatory activities of hepatocyte growth factor in post-ischemic heart failure","volume":"39","author":"Rong","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"B89","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biomaterials.2014.12.021","article-title":"Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction","volume":"45","author":"Sonnenberg","year":"2015","journal-title":"Biomaterials"},{"key":"B90","doi-asserted-by":"crossref","first-page":"II230","DOI":"10.1161\/01.cir.0000087444.53354.66","article-title":"Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure","volume":"108","author":"Jayasankar","year":"2003","journal-title":"Circulation"},{"key":"B91","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ejcts.2008.05.045","article-title":"Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model","volume":"34","author":"Cho","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1161\/CIRCULATIONAHA.110.010264","article-title":"Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure","volume":"124","author":"Banquet","year":"2011","journal-title":"Circulation"},{"key":"B93","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jacc.2004.04.042","article-title":"Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a \u201cfunctional\u201d gene using ultrasonic microbubble destruction","volume":"44","author":"Kondo","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"eaay6994","DOI":"10.1126\/sciadv.aay6994","article-title":"In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair","volume":"6","author":"Park","year":"2020","journal-title":"Sci Adv"},{"key":"B95","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.biomaterials.2015.10.010","article-title":"Nanoparticle-enhanced generation of gene-transfected mesenchymal stem cells for in vivo cardiac repair","volume":"74","author":"Zhu","year":"2016","journal-title":"Biomaterials"},{"key":"B96","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2174\/1566523218666180404162209","article-title":"Safety and efficacy of adenovirus carrying hepatocyte growth factor gene by percutaneous endocardial injection for treating post-infarct heart failure: a phase IIa clinical trial","volume":"18","author":"Meng","year":"2018","journal-title":"Curr Gene Ther"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11033-008-9315-3","article-title":"Phase I clinical trial on intracoronary administration of ad-hHGF treating severe coronary artery disease","volume":"36","author":"Yang","year":"2009","journal-title":"Mol Biol Rep"},{"key":"B98","doi-asserted-by":"publisher","first-page":"REVIEWS3005","DOI":"10.1186\/gb-2001-2-3-reviews3005","article-title":"Fibroblast growth factors","volume":"2","author":"Ornitz","year":"2001","journal-title":"Genome Biol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2004.05.067","article-title":"Fibroblast growth factor-1 improves cardiac functional recovery and enhances cell survival after ischemia and reperfusion: a fibroblast growth factor receptor, protein kinase C, and tyrosine kinase-dependent mechanism","volume":"44","author":"Palmen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3389\/fphar.2020.01193","article-title":"Basic fibroblast growth factor attenuates injury in myocardial infarction by enhancing hypoxia-inducible factor-1 alpha accumulation","volume":"11","author":"Rao","year":"2020","journal-title":"Front Pharmacol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbrc.2020.04.053","article-title":"The protective role of bFGF in myocardial infarction and hypoxia cardiomyocytes by reducing oxidative stress via Nrf2","volume":"527","author":"Tong","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B102","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jconrel.2019.09.005","article-title":"Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote cardiac tissue vascularization following myocardial infarction","author":"Fan","year":"2019","journal-title":"J Controlled Release"},{"key":"B103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00395-019-0768-4","article-title":"Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143\/EGR1 axis","volume":"115","author":"Li","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1089\/104303404323142024","article-title":"Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor 4: report of preclinical data","volume":"15","author":"Gao","year":"2004","journal-title":"Hum Gene Ther"},{"key":"B105","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/nm0596-534","article-title":"Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart","volume":"2","author":"Giordano","year":"1996","journal-title":"Nat Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/01.RES.0000162099.01268.d1","article-title":"Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle","volume":"96","author":"Suzuki","year":"2005","journal-title":"Circ Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cardiores.2006.02.019","article-title":"Redox regulation of cardiac calcium channels and transporters","volume":"71","author":"Zima","year":"2006","journal-title":"Cardiovasc Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.addr.2009.01.005","article-title":"Antioxidant enzyme gene transfer for ischemic diseases","volume":"61","author":"Wu","year":"2009","journal-title":"Adv Drug Delivery Rev"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1161\/01.CIR.103.14.1893","article-title":"Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction","volume":"103","author":"Li","year":"2001","journal-title":"Circulation"},{"key":"B110","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1161\/CIRCIMAGING.112.000320","article-title":"Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling","volume":"6","author":"Konkalmatt","year":"2013","journal-title":"Circulation Cardiovascular Imaging"},{"key":"B111","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/ijms20010187","article-title":"New therapeutic implications of endothelial nitric oxide synthase (eNOS) function\/dysfunction in cardiovascular disease","volume":"20","author":"Daiber","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B112","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.lfs.2004.11.028","article-title":"Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction","volume":"76","author":"Smith","year":"2005","journal-title":"Life Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/CIRCULATIONAHA.107.717702","article-title":"Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction","volume":"118","author":"Fraccarollo","year":"2008","journal-title":"Circulation"},{"key":"B114","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00395-009-0039-x","article-title":"Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease: an in vitro study","volume":"104","author":"Kaur","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.biomaterials.2018.01.021","article-title":"An injectable conductive hydrogel encapsulating plasmid DNA-eNOs and ADSCs for treating myocardial infarction","volume":"160","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"key":"B116","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10557-016-6704-z","article-title":"Mesenchymal stem cells with eNOS over-expression enhance cardiac repair in rats with myocardial infarction","volume":"31","author":"Chen","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1161\/CIRCRESAHA.110.237644","article-title":"Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling","volume":"108","author":"Qian","year":"2011","journal-title":"Circ Res"},{"key":"B118","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.26355\/eurrev_201906_18075","article-title":"HSP20-mediated Cardiomyocyte exosomes improve cardiac function in mice with myocardial infarction by activating akt signaling pathway","volume":"23","author":"Yu","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"105162","DOI":"10.1016\/j.phrs.2020.105162","article-title":"Therapeutic perspectives of heat shock proteins and their protein-protein interactions in myocardial infarction","volume":"160","author":"Wu","year":"2020","journal-title":"Pharmacol Res"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1161\/01.CIR.103.13.1787","article-title":"Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation","volume":"103","author":"Lin","year":"2001","journal-title":"Circulation"},{"key":"B121","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/01.CIR.103.6.877","article-title":"Gene transfer of heat-shock protein 70 reduces infarct size in vivo after ischemia\/reperfusion in the rabbit heart","volume":"103","author":"Okubo","year":"2001","journal-title":"Circulation"},{"key":"B122","doi-asserted-by":"publisher","first-page":"C525","DOI":"10.1152\/ajpcell.00122.2019","article-title":"p38-Regulated\/activated protein kinase plays a pivotal role in protecting heart against ischemia-reperfusion injury and preserving cardiac performance","volume":"317","author":"Zhao","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1096\/fj.05-5618fje","article-title":"P38 kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms","volume":"20","author":"Tenhunen","year":"2006","journal-title":"FASEB J"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1476-5381.2010.00793.x","article-title":"The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits","volume":"160","author":"Heusch","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13287-019-1544-y","article-title":"IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway","volume":"11","author":"Lin","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"B126","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.1038\/s41598-020-64097-y","article-title":"Microencapsulated insulin-like growth factor-1 therapy improves cardiac function and reduces fibrosis in a porcine acute myocardial infarction model","volume":"10","author":"Baez-Diaz","year":"2020","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1096\/fj.03-1148fje","article-title":"In vivo transfer of soluble TNF-alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats","volume":"18","author":"Sugano","year":"2004","journal-title":"FASEB J"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1136\/heartjnl-2013-303648","article-title":"Cardiovascular effects of tumour necrosis factor alpha antagonism in patients with acute myocardial infarction: a first in human study","volume":"99","author":"Padfield","year":"2013","journal-title":"Heart"},{"key":"B129","doi-asserted-by":"publisher","first-page":"107754","DOI":"10.1016\/j.pharmthera.2020.107754","article-title":"The emerging role of leukemia inhibitory factor in cancer and therapy","volume":"221","author":"Zhang","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B130","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.CIR.0000081773.76337.44","article-title":"Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction","volume":"108","author":"Zou","year":"2003","journal-title":"Circulation"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e0156562","DOI":"10.1371\/journal.pone.0156562","article-title":"Leukemia inhibitory factor enhances endogenous cardiomyocyte regeneration after myocardial infarction","volume":"11","author":"Kanda","year":"2016","journal-title":"PLoS One"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/nm1313","article-title":"Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling","volume":"11","author":"Kusano","year":"2005","journal-title":"Nat Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.7150\/thno.40461","article-title":"Cardioprotective effect of sonic hedgehog ligand in pig models of ischemia reperfusion","volume":"10","author":"Ghaleh","year":"2020","journal-title":"Theranostics"},{"key":"B134","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/01.HYP.0000036035.41122.99","article-title":"Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction","volume":"40","author":"Agata","year":"2002","journal-title":"Hypertension"},{"key":"B135","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/cvr\/cvn223","article-title":"Tissue kallikrein promotes neovascularization and improves cardiac function by the akt-glycogen synthase kinase-3beta pathway","volume":"80","author":"Yao","year":"2008","journal-title":"Cardiovasc Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/aps.2008.10","article-title":"Assessment of myocardial blood perfusion improved by CD151 in a pig myocardial infarction model","volume":"30","author":"Zuo","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"B137","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000446639","article-title":"Delivery of CD151 by ultrasound microbubbles in rabbit myocardial infarction","volume":"135","author":"Yang","year":"2016","journal-title":"Cardiology"},{"key":"B138","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2119\/molmed.2009.00025","article-title":"CD151 gene delivery after myocardial infarction promotes functional neovascularization and activates FAK signaling","volume":"15","author":"Zuo","year":"2009","journal-title":"Mol Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.gt.3302589","article-title":"Adenoviral gene transfer of akt enhances myocardial contractility and intracellular calcium handling","volume":"13","author":"Cittadini","year":"2006","journal-title":"Gene Ther"},{"key":"B140","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/1521-2254(200009\/10)2:5%3C326::AID-JGM133%3E3.0.CO;2-1","article-title":"Cardiac functional improvement by a human bcl-2 transgene in a mouse model of ischemia\/reperfusion injury","volume":"2","author":"Brocheriou","year":"2000","journal-title":"J Gene Med"},{"key":"B141","doi-asserted-by":"crossref","first-page":"I212","DOI":"10.1161\/01.cir.0000032907.33237.55","article-title":"Viral gene transfer of the antiapoptotic factor bcl-2 protects against chronic postischemic heart failure","volume":"106","author":"Chatterjee","year":"2002","journal-title":"Circulation"},{"key":"B142","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/08977190701781289","article-title":"Cardioprotective role of cardiotrophin-1 gene transfer in a murine model of myocardial infarction","volume":"25","author":"Ruixing","year":"2007","journal-title":"Growth Factors"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/CIRCULATIONAHA.117.029003","article-title":"In vivo functional selection identifies cardiotrophin-1 as a cardiac engraftment factor for mesenchymal stromal cells","volume":"136","author":"Bortolotti","year":"2017","journal-title":"Circulation"},{"key":"B144","doi-asserted-by":"publisher","first-page":"104793","DOI":"10.1016\/j.phrs.2020.104793","article-title":"Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology","volume":"156","author":"Jozefczuk","year":"2020","journal-title":"Pharmacol Res"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1089\/hum.2007.036","article-title":"Adenoviral gene transfer of sphingosine kinase 1 protects heart against ischemia\/reperfusion-induced injury and attenuates its postischemic failure","volume":"18","author":"Duan","year":"2007","journal-title":"Hum Gene Ther"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","article-title":"Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report","volume":"36","author":"Menasche","year":"2015","journal-title":"Eur Heart J"},{"key":"B147","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","article-title":"Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I\/IIa double-blind, randomized controlled trial","volume":"115","author":"Losordo","year":"2007","journal-title":"Circulation"},{"key":"B148","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/eurheartj\/ehx188","article-title":"Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial","volume":"38","author":"Wollert","year":"2017","journal-title":"Eur Heart J"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/eurheartj\/ehp073","article-title":"Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre myocardial regeneration by intracoronary infusion of selected population of stem cells in acute myocardial infarction (REGENT) trial","volume":"30","author":"Tendera","year":"2009","journal-title":"Eur Heart J"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jacc.2004.08.014","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial","volume":"44","author":"Schachinger","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"Jama"},{"key":"B153","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1093\/eurheartj\/ehaa651","article-title":"The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial","volume":"41","author":"Mathur","year":"2020","journal-title":"Eur Heart J"},{"key":"B154","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3343\/alm.2023.0382","article-title":"Manufacturing cell and gene therapies: challenges in clinical translation","volume":"44","author":"Lee","year":"2024","journal-title":"Ann Lab Med"},{"key":"B155","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41556-023-01087-y","article-title":"Progress and challenges in stem cell biology","volume":"25","author":"Apostolou","year":"2023","journal-title":"Nat Cell Biol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41434-023-00390-5","article-title":"Successes and challenges in clinical gene therapy","volume":"30","author":"Kohn","year":"2023","journal-title":"Gene Ther"},{"key":"B157","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/sctm.19-0375","article-title":"Unleashing the cure: overcoming persistent obstacles in the translation and expanded use of hematopoietic stem cell-based therapies","volume":"9","author":"Talib","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"B158","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1002\/sct3.13035","article-title":"Developing standards to support the clinical translation of stem cells","volume":"10","author":"Cao","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"B159","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.stemcr.2016.05.001","article-title":"Setting global standards for stem cell research and clinical translation: the 2016 ISSCR guidelines","volume":"6","author":"Daley","year":"2016","journal-title":"Stem Cell Rep"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1421854","DOI":"10.3389\/fimmu.2024.1421854","article-title":"Advances and clinical challenges of mesenchymal stem cell therapy","volume":"15","author":"Mei","year":"2024","journal-title":"Front Immunol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12964-023-01227-9","article-title":"Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction","volume":"21","author":"Liu","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B162","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.3390\/ijms21175952","article-title":"Biomaterials loaded with growth factors\/cytokines and stem cells for cardiac tissue regeneration","volume":"21","author":"Smagul","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B163","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/14712598.2023.2245329","article-title":"Stem cell therapy for acute myocardial infarction: mesenchymal stem cells and induced pluripotent stem cells","volume":"23","author":"Clavellina","year":"2023","journal-title":"Expert Opin Biol Ther"},{"key":"B164","doi-asserted-by":"publisher","first-page":"11370","DOI":"10.1073\/pnas.1816847116","article-title":"Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-\u03baB-driven inflammation and cardiovascular risk","volume":"116","author":"Zannas","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B165","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13287-024-03891-1","article-title":"Mid- to long-term efficacy and safety of stem cell therapy for acute myocardial infarction: a systematic review and meta-analysis","volume":"15","author":"Lee","year":"2024","journal-title":"Stem Cell Res Ther"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1540066\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:52:43Z","timestamp":1739947963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1540066\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":165,"alternative-id":["10.3389\/fcvm.2025.1540066"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1540066","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"article-number":"1540066"}}